Literature DB >> 23067331

Thyroid storm due to inappropriate administration of a compounded thyroid hormone preparation successfully treated with plasmapheresis.

Sujeet Jha1, Swati Waghdhare, Rajashekar Reddi, Priyanka Bhattacharya.   

Abstract

BACKGROUND: Thyroid storm (TS) is a rare life-threatening condition that is characterized by fever and altered mental status precipitated by endogenous or exogenous critical events, illness/injury, acute iodine load, and thyroid or non thyroid surgery. A large number of thyroid extracts are available and extensively used, even though they are not recommended clinically in hypothyroid or euthyroid patients. Consumption of such products can be dangerous and result in life-threatening TS. Here, we report a case of TS caused by inadvertent intake of very high dosages of triiodothyronine (T3) and thyroxine (T4) in compounded thyroid extracts. Plasmapheresis may be considered an option for the management of exogenous TS. PATIENT
FINDINGS: A 62-year-old woman with no significant past medical history presented with severe myalgia, fever, tachycardia, and blood pressure of 170/80 mmHg, which precipitated to an altered mental state within 24 hours. Neurological examination did not reveal any focal deficit or any signs of meningeal irritation. Further investigation revealed that she had been taking thyroid supplements. The patient had accidentally been supplied with a batch of thyroid extract pills that had an inadvertently high content of T4. Her free T3 (FT3) and free T4 (FT4) levels were found to be very high beyond the laboratory readable range (FT3>30 pg/mL; FT4>6.06 ng/dL; thyrotropin [TSH]=0.07 IU/mL).
SUMMARY: Three days post commencement of standard conservative management of TS, the patient developed posterior reversible encephalopathy syndrome, resulting in a seizure. She remained unresponsive and in a poor mental state. The confirmed exogenous etiology for TS led to a decision to conduct plasmapheresis. Plasmapheresis conducted for two consecutive days proved successful as a therapeutic measure for TS and improved her thyroid profile as well as her mental state.
CONCLUSIONS: The inappropriate use of thyroid extracts in euthyroid and hypothyroid patients can result in life-threatening TS. Plasmapheresis is probably a life-saving treatment in patients who are exposed to amounts of thyroid hormone far in excess of that usually produced by the thyroid gland.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23067331     DOI: 10.1089/thy.2011.0353

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  10 in total

1.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

2.  Thyrotoxicosis due to 1000-fold error in compounded liothyronine: A case elucidated by mass spectrometry.

Authors:  Wajid Khan; Grace Van Der Gugten; Daniel T Holmes
Journal:  Clin Mass Spectrom       Date:  2018-11-30

3.  Changes of Thyroid Hormones and Their Binding Proteins during Plasma Exchange for Polyneuropathy in a Patient with Substituted Hypothyroidism due to Hashimoto's Thyroiditis.

Authors:  Stefan Jenni; Marcel Adler; Simone Lanz; Behrouz Mansouri Taleghani; Emanuel R Christ
Journal:  Transfus Med Hemother       Date:  2015-11-04       Impact factor: 3.747

4.  Therapeutic plasma exchange and continuous renal replacement therapy for severe hyperthyroidism and multi-organ failure: A case report.

Authors:  Jun-Hui Ba; Ben-Quan Wu; Yan-Hong Wang; Yun-Feng Shi
Journal:  World J Clin Cases       Date:  2019-02-26       Impact factor: 1.337

5.  High scored thyroid storm after stomach cancer perforation: A case report.

Authors:  Seung Min Baik; Yejune Pae; Jae-Myeong Lee
Journal:  World J Clin Cases       Date:  2022-08-26       Impact factor: 1.534

6.  Severe TSH Elevation and Pituitary Enlargement After Changing Thyroid Replacement to Compounded T4/T3 Therapy.

Authors:  Adlai L Pappy; Nelson Oyesiku; Adriana Ioachimescu
Journal:  J Investig Med High Impact Case Rep       Date:  2016-08-02

Review 7.  Management of hypothyroidism with combination thyroxine (T4) and triiodothyronine (T3) hormone replacement in clinical practice: a review of suggested guidance.

Authors:  Colin Dayan; Vijay Panicker
Journal:  Thyroid Res       Date:  2018-01-17

8.  Exogenous T3 toxicosis following consumption of a contaminated weight loss supplement.

Authors:  R D'Arcy; M McDonnell; K Spence; C H Courtney
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-08-29

9.  Severe Hyperthyroidism Complicated by Agranulocytosis Treated with Therapeutic Plasma Exchange: Case Report and Review of the Literature.

Authors:  Vishnu Garla; Karthik Kovvuru; Shradha Ahuja; Venkatataman Palabindala; Bharat Malhotra; Sohail Abdul Salim
Journal:  Case Rep Endocrinol       Date:  2018-01-10

Review 10.  Thyrotoxicosis after massive triiodothyronine (LT3) overdose: a coast-to-coast case series and review.

Authors:  Zhiheng H He; Yan Li; Nitin Trivedi; Sabrina Gill; James V Hennessey
Journal:  Drugs Context       Date:  2020-01-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.